KMT2C and Lymphadenopathy: In conclusion, aged Mll3Δ/Δ mice did not develop MDS or AML, but loss of Mll3 catalytic function recapitulated some previously reported phenotypes and resulted in the novel finding of splenomegaly and lymphadenopathy.